INCB 024360-analog

Pricing Availability   Qty
说明: Potent indoleamine 2,3-dioxygenase (IDO) inhibitor
化学名: 4-Amino-N'-(3-chloro-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide
纯度: ≥99% (HPLC)
说明书
引用文献
评论
文献 (3)

生物活性 for INCB 024360-analog

INCB 024360-analog is a potent indoleamine 2,3-dioxygenase (IDO) inhibitor (IC50 values are 19 and 67 nM in enzymatic activity and HeLa cell assays, respectively). Decreases kynurenine levels in plasma and reduces tumor growth in vivo. Cell membrane permeable.

化合物库 for INCB 024360-analog

INCB 024360-analog is also offered as part of the Tocriscreen 2.0 Max. 了解 Tocris 化合物库的更多信息。

技术数据 for INCB 024360-analog

分子量 271.64
公式 C9H7ClFN5O2
储存 Store at -20°C
纯度 ≥99% (HPLC)
CAS Number 914471-09-3
PubChem ID 11978742
InChI Key MUVQOOPKPBEAJZ-VQHVLOKHSA-N
Smiles O/N=C(NC1=CC(Cl)=C(F)C=C1)/C2=NON=C2N

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for INCB 024360-analog

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
DMSO 27.16 100
ethanol 27.16 100

制备储备液 for INCB 024360-analog

以下数据基于产品分子量 271.64。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
1 mM 3.68 mL 18.41 mL 36.81 mL
5 mM 0.74 mL 3.68 mL 7.36 mL
10 mM 0.37 mL 1.84 mL 3.68 mL
50 mM 0.07 mL 0.37 mL 0.74 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

产品说明书 for INCB 024360-analog

参考文献 for INCB 024360-analog

参考文献是支持产品生物活性的出版物。

Weinmann (2016) Cancer immunotherapy: selected targets and small-molecule modulators. Chem.Med.Chem. 11 450 PMID: 26836578

Yue et al (2009) Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model. J.Med.Chem. 52 7364 PMID: 19507862

Dounay et al (2015) Challenges and opportunities in the discovery of new therapeutics targeting the kynurenine pathway. J.Med.Chem. 58 8762 PMID: 26207924


If you know of a relevant reference for INCB 024360-analog, please let us know.

按产品操作查看相关产品

查看全部 Indoleamine 2,3 dioxygenase Inhibitors

关键词: INCB 024360-analog, INCB 024360-analog supplier, 1, Indoleamine, 2,3-dioxygenase, IDO, inhibitors, inhibits, cancer, immunology, 2,3, dioxygenase, Immune, Checkpoints, 6007, Tocris Bioscience

篇 INCB 024360-analog 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 INCB 024360-analog 的引用文献。 您是否知道使用了 Tocris INCB 024360-analog 的优秀论文? 请告知我们.

INCB 024360-analog 的评论

目前没有该产品的评论。 Be the first to review INCB 024360-analog and earn rewards!

Have you used INCB 024360-analog?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.

Cancer Metabolism Poster

Cancer Metabolism Poster

This poster summarizes the main metabolic pathways in cancer cells and highlights potential targets for cancer therapeutics. Genetic changes and epigenetic modifications in cancer cells alter the regulation of cellular metabolic pathways providing potential cancer therapeutic targets.

Huntington's Disease Poster

Huntington's Disease Poster

Huntington's disease (HD) is a severe monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the effects of mutant huntingtin aggregation implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.